160 related articles for article (PubMed ID: 32723430)
1. Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.
Das MK; Chaudhary A; Bryan A; Wener MH; Fink SL; Morishima C
Emerg Infect Dis; 2020 Oct; 26(10):2501-2503. PubMed ID: 32723430
[TBL] [Abstract][Full Text] [Related]
2. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
Thevis M; Knoop A; Schaefer MS; Dufaux B; Schrader Y; Thomas A; Geyer H
Drug Test Anal; 2020 Jul; 12(7):994-997. PubMed ID: 32386354
[No Abstract] [Full Text] [Related]
3. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG.
Sapkal G; Shete-Aich A; Jain R; Yadav PD; Sarkale P; Lakra R; Baradkar S; Deshpande GR; Mali D; Tilekar BN; Majumdar T; Kaushal H; Gurav Y; Gupta N; Mohandas S; Deshpande K; Kaduskar O; Salve M; Patil S; Gaikwad S; Sugunan AP; Ashok M; Giri S; Shastri J; Abraham P; Gangakhedkar RR;
Indian J Med Res; 2020 May; 151(5):444-449. PubMed ID: 32611915
[TBL] [Abstract][Full Text] [Related]
4. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
Risch M; Weber M; Thiel S; Grossmann K; Wohlwend N; Lung T; Hillmann D; Ritzler M; Ferrara F; Bigler S; Egli K; Bodmer T; Imperiali M; Salimi Y; Fleisch F; Cusini A; Renz H; Kohler P; Vernazza P; Kahlert CR; Paprotny M; Risch L
Biomed Res Int; 2020; 2020():9878453. PubMed ID: 33224987
[TBL] [Abstract][Full Text] [Related]
5. The Promise and Peril of Antibody Testing for COVID-19.
Abbasi J
JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
[No Abstract] [Full Text] [Related]
6. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
[TBL] [Abstract][Full Text] [Related]
7. Serum IgA, IgM, and IgG responses in COVID-19.
Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
[No Abstract] [Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.
Okba NMA; Müller MA; Li W; Wang C; GeurtsvanKessel CH; Corman VM; Lamers MM; Sikkema RS; de Bruin E; Chandler FD; Yazdanpanah Y; Le Hingrat Q; Descamps D; Houhou-Fidouh N; Reusken CBEM; Bosch BJ; Drosten C; Koopmans MPG; Haagmans BL
Emerg Infect Dis; 2020 Jul; 26(7):1478-1488. PubMed ID: 32267220
[TBL] [Abstract][Full Text] [Related]
9. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
Choe PG; Kang CK; Suh HJ; Jung J; Kang E; Lee SY; Song KH; Kim HB; Kim NJ; Park WB; Kim ES; Oh MD
Emerg Infect Dis; 2020 Oct; 26(10):2484-2487. PubMed ID: 32579877
[TBL] [Abstract][Full Text] [Related]
10. Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.
Theel ES; Harring J; Hilgart H; Granger D
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513859
[TBL] [Abstract][Full Text] [Related]
11. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays.
Kohmer N; Westhaus S; Rühl C; Ciesek S; Rabenau HF
J Clin Virol; 2020 Aug; 129():104480. PubMed ID: 32505777
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
[TBL] [Abstract][Full Text] [Related]
13. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
[TBL] [Abstract][Full Text] [Related]
14. Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
DomBourian MG; Annen K; Huey L; Andersen G; Merkel PA; Jung S; Dominguez SR; Knight V
J Immunol Methods; 2020 Nov; 486():112837. PubMed ID: 32828791
[TBL] [Abstract][Full Text] [Related]
15. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
[TBL] [Abstract][Full Text] [Related]
16. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG.
Krüttgen A; Cornelissen CG; Dreher M; Hornef M; Imöhl M; Kleines M
J Clin Virol; 2020 Jul; 128():104394. PubMed ID: 32416599
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity, specificity, predictive values in serological Covid-19 tests].
Duca P
Epidemiol Prev; 2020; 44(2-3):189-190. PubMed ID: 32631019
[No Abstract] [Full Text] [Related]
18. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
19. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
[No Abstract] [Full Text] [Related]
20. Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study.
Pérez-García F; Pérez-Tanoira R; Romanyk J; Arroyo T; Gómez-Herruz P; Cuadros-González J
J Clin Virol; 2020 Aug; 129():104473. PubMed ID: 32504945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
